HbA1c values and hospital admissions in children and adolescents receiving continuous subcutaneous insulin infusion therapy
- 30 July 2018
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 36 (1) , 88-95
Abstract
Aims: To assess HbA1c values and hospitalization rates before, during and after continuous subcutaneous insulin infusion (CSII) therapy.Methods: Demographic and hospitalization data were extracted from 161 individuals with Type 1 diabetes who received continuous subcutaneous insulin infusion (CSII) therapy between 2002 and 2013 at the Leeds Children and Young People's Diabetes Service for those aged < 20 years. The median (range) age at CSII start was 11.9 (1.1–17.6) years. The median (range) follow‐up time was 2.3 (0–8.1) years. Random intercept models were used to compare HbA1c values before and during CSII initiation (and after CSII for those who discontinued it). Hospitalization rates were calculated for diabetic ketoacidosis and severe hypoglycaemia.Results: The mean HbA1c concentration decreased by 7 mmol/mol [95% CI 6–8; 0.6% (95% CI 0.5–0.7%)]. For the discontinued group (n=30), mean HbA1c decreased by 5 mmol/mol [95% CI 2–8; 0.4% (95% CI 0.2–0.7%)]. HbA1c returned to pre‐CSII start levels at the end of this therapy. Diabetic ketoacidosis admissions increased threefold during CSII compared with before CSII start [2.2 per 100 person‐years (95% CI 1.3 to 3.6) vs 7.4 per 100 person‐years (95% CI 5.1 to 10.8)] and was highest during the first year of CSII. No difference in severe hypoglycaemia incidence rate was found during CSII compared with the pre‐CSII period.Conclusions: Despite significant reductions in HbA1c levels for individuals treated with CSII, improvements are needed to reduce diabetic ketoacidosis hospitalizations for those new to the therapy.Keywords
Funding Information
- University of Leeds
This publication has 25 references indexed in Scilit:
- Diabetes Device Use in Adults With Type 1 Diabetes: Barriers to Uptake and Potential Intervention TargetsDiabetes Care, 2016
- Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registriesDiabetologia, 2015
- Does treatment with an insulin pump improve glycaemic control in children and adolescents with type 1 diabetes? A retrospective case-control studyPediatric Diabetes, 2014
- Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapyPediatric Diabetes, 2014
- Treatment satisfaction and glycemic control in young Type 1 diabetic patients in transition from pediatric health care: CSII versus MDIEndocrine, 2013
- Hypoglycaemia, fear of hypoglycaemia and quality of life in children with Type 1 diabetes and their parentsDiabetic Medicine, 2013
- Metabolic Control in Children with Diabetes Mellitus Who are Younger than 6 Years at Diagnosis: Continuous Subcutaneous Insulin Infusion as a First Line Treatment?The Journal of Pediatrics, 2010
- Use of Continuous Insulin Infusion Pumps in Young Children With Type 1 Diabetes: A Systematic ReviewJournal of Pediatric Health Care, 2009
- Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trialsPediatric Diabetes, 2009
- Embedding CSII therapy in the routine management of diabetes in children: a clinical audit of this service in LeedsPractical Diabetes International, 2009